Recombinant multi-species BAX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAX protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the BCL2 protein family. BCL2 family members form hetero- or homodimers and act as anti- or pro-apoptotic regulators that are involved in a wide variety of cellular activities. This protein forms a heterodimer with BCL2, and functions as an apoptotic activator. The association and the ratio of BAX to BCL2 also determines survival or death of a cell following an apoptotic stimulus. This protein is reported to interact with, and increase the opening of, the mitochondrial voltage-dependent anion channel (VDAC), which leads to the loss in membrane potential and the release of cytochrome c. The expression of this gene is regulated by the tumor suppressor P53 and has been shown to be involved in P53-mediated apoptosis. Multiple alternatively spliced transcript variants, which encode different isoforms, have been reported for this gene. [provided by RefSeq, Dec 2019]
The Alternative Names of target: Apoptosis regulator BAX,BAX,BCL2L4,Bax,Bcl-2-like protein 4 (Bcl2-L-4)
Go
to BAX products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0034-Ag-1/ GM-Tg-hg-IP0034-Ag-2 | Human BAX protein | Human |
| GM-Tg-rg-IP0034-Ag-1/ GM-Tg-rg-IP0034-Ag-2 | Rat BAX protein | Rat |
| GM-Tg-mg-IP0034-Ag-1/ GM-Tg-mg-IP0034-Ag-2 | Mouse BAX protein | Mouse |
| GM-Tg-cynog-IP0034-Ag-1/ GM-Tg-cynog-IP0034-Ag-2 | Cynomolgus/Rhesus macaque BAX protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0034-Ag-1/ GM-Tg-felg-IP0034-Ag-2 | Feline BAX protein | Feline |
| GM-Tg-cang-IP0034-Ag-1/ GM-Tg-cang-IP0034-Ag-2 | Canine BAX protein | Canine |
| GM-Tg-bovg-IP0034-Ag-1/ GM-Tg-bovg-IP0034-Ag-2 | Bovine BAX protein | Bovine |
| GM-Tg-equg-IP0034-Ag-1/ GM-Tg-equg-IP0034-Ag-2 | Equine BAX protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0034-Ag-1/ GM-Tg-hg-IP0034-Ag-2;
GM-Tg-rg-IP0034-Ag-1/ GM-Tg-rg-IP0034-Ag-2;
GM-Tg-mg-IP0034-Ag-1/ GM-Tg-mg-IP0034-Ag-2; GM-Tg-cynog-IP0034-Ag-1/ GM-Tg-cynog-IP0034-Ag-2; GM-Tg-felg-IP0034-Ag-1/ GM-Tg-felg-IP0034-Ag-2; GM-Tg-cang-IP0034-Ag-1/ GM-Tg-cang-IP0034-Ag-2; GM-Tg-bovg-IP0034-Ag-1/ GM-Tg-bovg-IP0034-Ag-2; GM-Tg-equg-IP0034-Ag-1/ GM-Tg-equg-IP0034-Ag-2 |
| Products Name | BAX protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BAX |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAX protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.